Cary, NC, United States of America

Regis Perichon

This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Metabolon, Inc.. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Regis Perichon

Introduction

Regis Perichon is an accomplished inventor based in Cary, NC (US). He has made significant contributions to the field of kidney function assessment through his innovative research and patents. His work focuses on biomarkers that are crucial for diagnosing and monitoring kidney-related conditions.

Latest Patents

Regis Perichon holds a patent titled "Biomarkers related to kidney function and methods using the same." This patent provides valuable insights into biomarkers of kidney function and outlines methods for assessing kidney function, diagnosing acute kidney injury, and chronic kidney disease. Additionally, it includes suites of small molecule entities that serve as biomarkers for chronic kidney disease.

Career Highlights

Regis Perichon is currently associated with Metabolon, Inc., where he continues to advance research in the field of biomarkers and kidney health. His expertise and innovative approach have positioned him as a key figure in this area of study.

Collaborations

Throughout his career, Regis has collaborated with notable colleagues, including Jeffery Edmond Cobb and Meredith V Brown. These partnerships have further enhanced the impact of his work in the medical and scientific communities.

Conclusion

Regis Perichon exemplifies the spirit of innovation in the field of kidney function research. His contributions through patents and collaborations continue to pave the way for advancements in medical diagnostics and treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…